Treatment efficacy of a probiotic preparation for non-alcoholic steatohepatitis: A pilot trial.

Short-term treatment with the probiotic cocktail caused significant improvement of liver inflammation without adverse events and, thus, may represent a promising candidate therapeutic approach for NASH.